Adrian Rawcliffe - Chief Executive Officer, Director at Adaptimmune Therapeutics PLC

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
ADAP on Nasdaq
All Insider Reports
All Insider Reports

Adrian Rawcliffe - trading volume in the past year for Adaptimmune Therapeutics PLC

Holdings reported by Adrian Rawcliffe for Adaptimmune Therapeutics PLC

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
American Depositary Shares representing Ordinary Shares 44.8K $30.2K $0.67 Jan 17, 2024 Direct
Option to purchase Ordinary Shares 1.7M Jan 15, 2024 Direct Ordinary Shares

Transactions reported by Adrian Rawcliffe for Adaptimmune Therapeutics PLC

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership